earnings
confidence high
sentiment negative
materiality 0.65
Better Choice Q3 net sales $11.9M (-10% YoY); net loss $6.5M vs $3.5M
SRx Health Solutions, Inc.
2022-Q3 EPS reported
-$0.51
revenue$45,394,000
- Net sales $11.9M, down from $13.2M in Q3 2021; YTD net sales $45.4M, up 30% YoY.
- Gross margin improved to 35% (adjusted 37%) from 29% in Q2 2022; loss from operations $6.4M.
- Extended revolving credit facility to $13.5M, removed going concern language from 10-Q.
- Adjusted EBITDA loss $2.9M vs $1.4M loss in Q3 2021; net loss $6.5M vs $3.5M.
- International net sales up 31% YoY; domestic softness due to channel destocking.